ArticleEuropean heart journal. Case reports2025

Use of rituximab for fulminant and refractory cases of immune checkpoint inhibitor induced myocyte injury clinically presenting with features of myasthenia gravis: a case series.

Imran Naeem Aziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.